---
$id: https://graph.org.ai/products/commodity/51241306
$type: Product
source: UNSPSC
code: "51241306"
title: "Alcloxa"
class: "51241300"
classTitle: "Astringents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Alcloxa

**UNSPSC Code**: 51241306
**Class**: [Astringents](Astringents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an astringent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 18B8O9DQA2. European Medicines Agency schedules Alcloxa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05301MIG. Alcloxa generally arises in the molecular formula C4H5N4O3.2AL.CL.4HO. The term ALCLOXA is an International Non-Proprietary Name or INN. ALCLOXA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alcloxa under HS 29332100 and SITC 51572. As of Q4 2014, ALCLOXA remains the US FDA Preferred Term for this commodity. Alcloxa bears US NLM identifiers UMLS ID C0771150 and NCI Concept Code C76518. SMILES: C1(C(=O)NC(=O)N1)NC(=O)N[Al]Cl.O.O.O.O.[Al].

